中国P站

Benzimidazole; Continuous flow chemistry; Heterogeneous catalysis; Process intensification; Green chemistry; Sulfonated resin; Heterocyclic synthesis; Flow reactors; Reaction optimization; Organic process research

Introduction

Benzimidazoles are nitrogen-containing heterocycles with extensive applications in medicinal chemistry, agrochemicals, and material science. They form the backbone of several drugs, including omeprazole, albendazole, and thiabendazole [1]. Traditional synthetic methods rely on batchwise condensation of o-phenylenediamines with aldehydes or acids using strong Brønsted or Lewis acids, which require high temperatures, prolonged reaction times, and generate acidic waste [2].

Continuous flow chemistry has emerged as a transformative platform in organic synthesis, offering superior heat and mass transfer, enhanced safety, scalability, and reduced waste [3]. Moreover, incorporating heterogeneous catalysts in flow systems allows for easy separation, reuse, and real-time process monitoring [4]. In this study, we develop a flow-based process for benzimidazole synthesis using Amberlyst-15, a sulfonated polystyrene resin, as a solid acid catalyst. The process minimizes solvent and energy consumption while maximizing throughput and purity.

Materials and Methods

All reagents were purchased from Sigma-Aldrich. A stainless-steel tubular flow reactor (10 mL volume) was packed with Amberlyst-15 and heated using a thermostatic oil bath. The reactor was connected to dual syringe pumps for precise reactant delivery.

Substrates including o-phenylenediamine (OPD) and a range of aromatic aldehydes (benzaldehyde, p-methoxybenzaldehyde, p-nitrobenzaldehyde) were dissolved in ethanol at 0.5 M concentration. Reaction parameters such as flow rate (0.1–0.5 mL/min), temperature (80–140°C), and residence time (2–12 min) were optimized using design of experiments (DoE) methodology. Products were collected in-line, cooled, and purified by recrystallization or flash chromatography.

Conversion and selectivity were monitored using HPLC and GC-MS. Catalyst leaching was assessed by ICP-OES. Catalyst reusability was tested over 20 reaction cycles.

Results

Initial experiments with benzaldehyde and OPD showed 93% conversion at 120°C with a 5-minute residence time and 0.25 mL/min flow rate. Increasing temperature to 130°C improved conversion slightly (96%) but promoted trace by-product formation. A residence time of 8 minutes proved optimal for substituted benzaldehydes.

Amberlyst-15 showed robust catalytic performance with negligible leaching. Over 20 cycles, product yield remained above 91%, and FTIR analysis of the catalyst confirmed structural stability. Ethanol served as both solvent and benign reaction medium [5].

Yields of substituted benzimidazoles ranged from 90% to 97%, depending on electronic effects of the aldehyde substituents. Electron-donating groups accelerated reaction rates slightly, while electron-withdrawing groups required marginally longer residence times. Reaction mixtures were clean, with minimal post-processing.

Compared to batch synthesis, the flow process reduced solvent usage by 65%, energy consumption by 45%, and increased productivity by 300% based on space-time yield [6].

Discussion

The successful implementation of a continuous flow synthesis for benzimidazoles underscores the advantages of process intensification in organic synthesis. The use of Amberlyst-15 offered a robust, reusable, and easy-to-handle solid acid that eliminated the need for homogeneous mineral acids, improving both environmental and operational safety profiles [7].

Continuous flow conditions enabled precise control over residence time, temperature, and mixing, leading to higher selectivity and reduced side-product formation. The process performed consistently across a variety of aromatic aldehydes, demonstrating broad substrate scope [8].

The catalyst's recyclability and negligible leaching affirm its industrial applicability, particularly in GMP-compliant settings where solid catalysts can simplify purification and waste treatment [9]. The process' scalability and potential for automation suggest its integration into modular continuous manufacturing platforms for heterocyclic drugs.

Conclusion

A scalable, efficient continuous flow process for the synthesis of benzimidazoles was developed using Amberlyst-15 as a heterogeneous acid catalyst. The process delivered high yields with excellent selectivity and catalyst reusability under mild conditions. This green and intensified method serves as a valuable alternative to traditional batch synthesis for heterocycle manufacturing in the pharmaceutical industry.

Conflicts of Interest

The authors declare no competing financial or commercial interests.